BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mongan D, Föcking M, Healy C, Susai SR, Heurich M, Wynne K, Nelson B, McGorry PD, Amminger GP, Nordentoft M, Krebs MO, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Borgwardt S, Ruhrmann S, Sachs G, Pantelis C, van der Gaag M, de Haan L, Valmaggia L, Pollak TA, Kempton MJ, Rutten BPF, Whelan R, Cannon M, Zammit S, Cagney G, Cotter DR, McGuire P; European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) High Risk Study Group. Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence. JAMA Psychiatry 2021;78:77-90. [PMID: 32857162 DOI: 10.1001/jamapsychiatry.2020.2459] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferrara M, Franchini G, Funaro M, Cutroni M, Valier B, Toffanin T, Palagini L, Zerbinati L, Folesani F, Murri MB, Caruso R, Grassi L. Machine Learning and Non-Affective Psychosis: Identification, Differential Diagnosis, and Treatment. Curr Psychiatry Rep 2022. [DOI: 10.1007/s11920-022-01399-0] [Reference Citation Analysis]
2 Oraki Kohshour M, Kannaiyan NR, Falk AJ, Papiol S, Heilbronner U, Budde M, Kalman JL, Schulte EC, Rietschel M, Witt S, Forstner AJ, Heilmann-heimbach S, Nöthen MM, Spitzer C, Malchow B, Müller T, Wiltfang J, Falkai P, Schmitt A, Rossner MJ, Nilsson P, Schulze TG. Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles. Transl Psychiatry 2022;12:471. [DOI: 10.1038/s41398-022-02228-x] [Reference Citation Analysis]
3 Susai SR, Healy C, Mongan D, Heurich M, Byrne JF, Cannon M, Cagney G, Wynne K, Markulev C, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Street R, Thompson A, Yung AR, Nelson B, McGorry PD, Föcking M, Amminger GP, Cotter D. Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis. Transl Psychiatry 2022;12:454. [PMID: 36307392 DOI: 10.1038/s41398-022-02217-0] [Reference Citation Analysis]
4 Lång U, Ramsay H, Yates K, Veijola J, Gyllenberg D, Clarke MC, Leacy FP, Gissler M, Kelleher I. Potential for prediction of psychosis and bipolar disorder in Child and Adolescent Mental Health Services: a longitudinal register study of all people born in Finland in 1987. World Psychiatry 2022;21:436-43. [PMID: 36073707 DOI: 10.1002/wps.21009] [Reference Citation Analysis]
5 Byrne JF, Healy C, Mongan D, Susai SR, Zammit S, Fӧcking M, Cannon M, Cotter DR. Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort. Transl Psychiatry 2022;12:377. [PMID: 36085284 DOI: 10.1038/s41398-022-02142-2] [Reference Citation Analysis]
6 Cotter D, Healy C, Staines L, Mongan D, Cannon M. Broadening the Parameters of Clinical High Risk for Psychosis. Am J Psychiatry 2022;179:593-5. [PMID: 36048484 DOI: 10.1176/appi.ajp.20220612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Staines L, Healy C, Coughlan H, Clarke M, Kelleher I, Cotter D, Cannon M. Psychotic experiences in the general population, a review; definition, risk factors, outcomes and interventions. Psychol Med 2022;:1-12. [PMID: 36004805 DOI: 10.1017/S0033291722002550] [Reference Citation Analysis]
8 Liu C, Liu C, Hsieh M, Hwang T, Lin Y, Chien Y, Hwu H. The plasma level of complement component 4A decreases with aripiprazole treatment in patients with early psychosis. Psychiatry Research 2022. [DOI: 10.1016/j.psychres.2022.114775] [Reference Citation Analysis]
9 Susai SR, Mongan D, Healy C, Cannon M, Cagney G, Wynne K, Byrne JF, Markulev C, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Street R, Thompson A, Ruth Yung A, Nelson B, McGorry PD, Föcking M, Paul Amminger G, Cotter D. Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial. Brain Behav Immun 2022;103:50-60. [PMID: 35341915 DOI: 10.1016/j.bbi.2022.03.013] [Reference Citation Analysis]
10 Rodrigues JE, Martinho A, Santos V, Santa C, Madeira N, Martins MJ, Pato CN, Macedo A, Manadas B. Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder. Int J Mol Sci 2022;23:5460. [PMID: 35628270 DOI: 10.3390/ijms23105460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hatzimanolis A, Foteli S, Stefanatou P, Ntigrintaki AA, Ralli I, Kollias K, Nikolaou C, Gazouli M, Stefanis NC. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability. Eur Arch Psychiatry Clin Neurosci 2022. [PMID: 35532796 DOI: 10.1007/s00406-022-01409-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bellon A, Feuillet V, Cortez-Resendiz A, Mouaffak F, Kong L, Hong LE, De Godoy L, Jay TM, Hosmalin A, Krebs MO. Dopamine-induced pruning in monocyte-derived-neuronal-like cells (MDNCs) from patients with schizophrenia. Mol Psychiatry 2022. [PMID: 35365810 DOI: 10.1038/s41380-022-01514-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Antonucci LA, Penzel N, Sanfelici R, Pigoni A, Kambeitz-Ilankovic L, Dwyer D, Ruef A, Sen Dong M, Öztürk ÖF, Chisholm K, Haidl T, Rosen M, Ferro A, Pergola G, Andriola I, Blasi G, Ruhrmann S, Schultze-Lutter F, Falkai P, Kambeitz J, Lencer R, Dannlowski U, Upthegrove R, Salokangas RKR, Pantelis C, Meisenzahl E, Wood SJ, Brambilla P, Borgwardt S, Bertolino A, Koutsouleris N; PRONIA Consortium . Using combined environmental-clinical classification models to predict role functioning outcome in clinical high-risk states for psychosis and recent-onset depression. Br J Psychiatry 2022;:1-17. [PMID: 35152923 DOI: 10.1192/bjp.2022.16] [Reference Citation Analysis]
14 Salazar de Pablo G, Soardo L, Cabras A, Pereira J, Kaur S, Besana F, Arienti V, Coronelli F, Shin JI, Solmi M, Petros N, Carvalho AF, Mcguire P, Fusar-poli P. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis. Epidemiol Psychiatr Sci 2022;31. [DOI: 10.1017/s2045796021000639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Kirisci L, Vanyukov MM. Substance Use: Disorders and Continuous Traits. Genetics of Substance Use 2022. [DOI: 10.1007/978-3-030-95350-8_1] [Reference Citation Analysis]
16 Češková E, Šilhán P. From Personalized Medicine to Precision Psychiatry? Neuropsychiatr Dis Treat 2021;17:3663-8. [PMID: 34934319 DOI: 10.2147/NDT.S337814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Petty A, Howes O, Eyles D. Animal models of relevance to the schizophrenia prodrome. Biological Psychiatry Global Open Science 2021. [DOI: 10.1016/j.bpsgos.2021.12.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Song W, Wang W, Liu Z, Cai W, Yu S, Zhao M, Lin GN. A Comprehensive Evaluation of Cross-Omics Blood-Based Biomarkers for Neuropsychiatric Disorders. J Pers Med 2021;11:1247. [PMID: 34945719 DOI: 10.3390/jpm11121247] [Reference Citation Analysis]
19 Ji E, Boerrigter D, Cai HQ, Lloyd D, Bruggemann J, O'Donnell M, Gallety C, Lloyd A, Liu D, Lenroot R, Weickert T, Shannon Weickert C. Peripheral complement is increased in schizophrenia and inversely related to cortical thickness. Brain Behav Immun 2021:S0889-1591(21)00610-3. [PMID: 34808287 DOI: 10.1016/j.bbi.2021.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Li Z, Zhang T, Xu L, Wei Y, Cui H, Tang Y, Liu X, Qian Z, Zhang H, Liu P, Li C, Wang J. Plasma metabolic alterations and potential biomarkers in individuals at clinical high risk for psychosis. Schizophr Res 2021;239:19-28. [PMID: 34800912 DOI: 10.1016/j.schres.2021.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Bellon A, Feuillet V, Cortez-resendiz A, Mouaffak F, Kong L, Hong LE, De Godoy L, Jay TM, Hosmalin A, Krebs M. Dopamine-induced pruning in Monocyte-Derived-Neuronal-like cells (MDNCs) from patients with Schizophrenia.. [DOI: 10.1101/2021.10.28.21265586] [Reference Citation Analysis]
22 Susai SR, Mongan D, Healy C, Cannon M, Nelson B, Markulev C, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Föcking M, Cotter D, Amminger GP. The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial. Brain Behav Immun 2021;99:147-56. [PMID: 34624483 DOI: 10.1016/j.bbi.2021.09.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Kalinowski A, Liliental J, Anker LA, Linkovski O, Culbertson C, Hall JN, Pattni R, Sabatti C, Noordsy D, Hallmayer JF, Mellins ED, Ballon JS, O'Hara R, Levinson DF, Urban AE. Increased activation product of complement 4 protein in plasma of individuals with schizophrenia. Transl Psychiatry 2021;11:486. [PMID: 34552056 DOI: 10.1038/s41398-021-01583-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
24 Jernbom Falk A, Galletly C, Just D, Toben C, Baune BT, Clark SR, Liu D, Nilsson P, Månberg A, Schubert KO. Autoantibody profiles associated with clinical features in psychotic disorders. Transl Psychiatry 2021;11:474. [PMID: 34518517 DOI: 10.1038/s41398-021-01596-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Heurich M, Föcking M, Mongan D, Cagney G, Cotter DR. Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis. Mol Psychiatry 2021. [PMID: 34226666 DOI: 10.1038/s41380-021-01197-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
26 Mongan D, Yin X, Brennan L, Cotter DR. Dysregulation of Lipid Metabolism Precedes Psychosis…So Is Psychosis a Metabolic Disorder? Biol Psychiatry 2021;89:209-11. [PMID: 33357628 DOI: 10.1016/j.biopsych.2020.10.017] [Reference Citation Analysis]
27 Maclachlan M, Murphy R, Daly M, Hyland P. Why it’s time to stop saying “mental illness”:  A commentary on the revision of the Irish Mental Health Act. HRB Open Res 2021;4:28. [DOI: 10.12688/hrbopenres.13235.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 van Os J, Pries LK, Ten Have M, de Graaf R, van Dorsselaer S, Bak M, Wittchen HU, Rutten BPF, Guloksuz S. Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association-The Example of Cannabis and Psychosis. Schizophr Bull 2021;47:594-603. [PMID: 33693921 DOI: 10.1093/schbul/sbab019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]